Molecular monitoring of treatment efficacy in human visceral leishmaniasis

Sutopa Roy,Srija Moulik,Surya Jyati Chaudhuri,Manab K Ghosh,R P Goswami,Bibhuti Saha,Mitali Chatterjee
DOI: https://doi.org/10.1093/trstmh/trad103
2024-01-15
Transactions of the Royal Society of Tropical Medicine and Hygiene
Abstract:Abstract Background Focused efforts of the visceral leishmaniasis elimination program have led to a drastic decline in cases, and the present challenge is disease monitoring, which this study aimed to assess. Methods A Leishmania kinetoplastid-targeted qPCR quantified parasite load at disease presentation, and following treatment completion (n=49); an additional 80 cases were monitored after completion of treatment. Results The parasite load at disease presentation was 13 461.00 (2560.00–37764.00)/μg gDNA, which upon completion of treatment reduced in 47 of 49 cases to 1(1–1)/μg gDNA, p<0.0001. In 80 cases that presented >2 months post-treatment, their parasite burden similarly decreased to 1(1–1)/μg gDNA except in 6 of 80 cases, which were qPCR positive. Conclusion In 129 cases of visceral leishmaniasis, qPCR by quantification of parasite burden proved effective for monitoring treatment.
public, environmental & occupational health,tropical medicine
What problem does this paper attempt to address?